表紙
市場調查報告書

全球生物電力醫療市場:產品,11個國家資料,競爭環境:分析與預測 (2019∼2025年)

Global Bioelectric Medicine Market: Focus on Product, 11 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2025

出版商 BIS Research Inc. 商品編碼 915117
出版日期 內容資訊 英文 318 Pages
商品交期: 最快1-2個工作天內
價格
全球生物電力醫療市場:產品,11個國家資料,競爭環境:分析與預測 (2019∼2025年) Global Bioelectric Medicine Market: Focus on Product, 11 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2025
出版日期: 2019年10月16日內容資訊: 英文 318 Pages
簡介

全球生物電力醫療市場,由於新興國家的擴大和技術進步,預計至2029年達到291億2,580萬美元。

本報告提供全球生物電力醫療市場相關調查,市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介相關資訊彙整。

摘要整理

第1章 產品定義

第2章 調查範圍

第3章 調查方法

第4章 產業分析

  • 法律規章方案
  • 專利分析
  • 產品平台

第5章 競爭環境

  • 概要
  • 主要的發展與策略
    • 產品上市,認證,認證
    • 合資企業,協定,聯合,聯盟
    • 合併和收購
    • 商務擴充
  • 脊髓刺激設備市場佔有率分析
  • 人工電子耳市場佔有率分析
  • 心律調節器,ICD市場佔有率分析
  • 成長佔有率分析

第6章 生物電力醫療的發展

第7章 全球生物電力醫療市場

  • 預測與限制
  • 全球市場方案
  • 市場趨勢
    • 概要
    • 影響分析
    • 推動市場的要素
    • 阻礙市場的要素
    • 市場機會

第8章 各產品類型市場

  • 概要
  • 競爭基準
  • 置入式生物電力醫療

第9章 全球市場

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 企業簡介

  • 概要
  • Abbott Laboratories
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • Cochlear Limited
  • electroCore, Inc.
  • Inspire Medical Systems, Inc.
  • LivaNova Plc
  • Medtronic Plc
  • MED-EL
  • Nevro Corp.
  • Nuvectra Corporation
  • NeuroMetrix, Inc
  • Omron Corporation
  • PIXIUM VISION
  • Second Sight Medical Products, Inc.
  • SetPoint Medical
  • Stimwave LLC
目錄
Product Code: BH160A

Global Bioelectric Medicine Market to Reach $29,125.8 Million by 2025.

Key Questions Answered in this Report:

  • What are the different types of bioelectric medicine available in the market and what are the benefits offered by them?
  • What are the major drivers, challenges, and opportunities in the global bioelectric medicine market?
  • What are the key development strategies implemented by the key players to stand out in this market?
  • What are the leading companies dominating the global bioelectric medicine market?
  • How many types of bioelectric medicine are available in the market, and which are the companies offering them?
  • Based on product type, which bioelectric medicine is anticipated to witness a massive rise in demand in the forecast period?
  • What are the perceptions of the investors about the global bioelectric medicine market?
  • What are the regulations pertaining to the global bioelectric medicine market? What are the initiatives implemented by different government bodies regulating the development and commercialization of bioelectric medicine?
  • What was the market value in 2018 of the leading segments and sub-segments of the global bioelectric medicine market?
  • How is each segment of the global bioelectric medicine market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2025?
  • How is the industry anticipated to evolve during the forecast period 2019-2025?
  • Which region is expected to contribute to the highest sales of the global bioelectric medicine market during the forecast period?
  • What are the leading trends and consumer preferences witnessed in global bioelectric medicine markets?

Global Bioelectric Medicine Market Forecast, 2019-2025

The global bioelectric medicine industry analysis by BIS Research projects the market to grow at a significant CAGR of 6.41% during the forecast period, 2019-2025. The bioelectric medicine market generated $18,636.4 million revenue in 2018.

The bioelectric medicine growth has been primarily attributed to the major drivers such as growing geriatric population leads to surge in exigency of bioelectric medicine, increasing burden of diseases inciting the use of bioelectric medicine, growing investments and funds for the development of novel therapeutics and electroceuticals, limited success rate of drugs targeting specific disease, increasing amount of adverse drug reaction, and upsurge in awareness level. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include growth in emerging countries and technological advancement in bioelectric medicine. However, there are significant challenges which are restraining the market growth. These challenges include product recall, exorbitant cost of electroceuticals, increased regulatory scrutiny, and complications and side effects associated with the bioelectric medicine devices.

Expert Quote

"The pacemaker represents the biggest opportunity in the bioelectric medicine market, as the demand of pacemaker and awareness of about the pacemakers are higher compare to other bioelectric medicine products. The upsurge prevalence of cardiovascular diseases and growing geriatric population has made it the largest sources of bioelectric medicine for the treatment of cardiovascular disorders."

Scope of the Market Intelligence on Bioelectric Medicine Market

The bioelectric medicine market research provides a holistic view of the market in terms of various factors influencing it, regulatory reforms, and technological advancements. The scope of this report is centered upon detailed study of the products, associated with the market. In addition, the study also includes exhaustive information on the market needs, details on the new products, competitive landscape, market share of leading players, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to the global bioelectric medicine market.

Market Segmentation

The bioelectric medicine market segmentation (on the basis of product type) is further segmented into implantable and non-implantable.

On the basis of implantable bioelectric medicine, the bioelectric medicine market is segmented into pacemaker, ICDs, spinal cord stimulation devices, cochlear implant, deep brain stimulation device, vagus nerve stimulation device, and others.

Key Companies in the Bioelectric Medicine Industry:

The key manufacturers that have been contributing significantly to the bioelectric medicine market include Abbott Laboratories, Boston Scientific Corporation, Cochlear Limited, electroCore, Inc., Inspire Medical Systems, Inc., LivaNova PLC, Medtronic Plc, Nevro Corp., Nuvectra Corporation, NeuroMetrix, Inc., OMRON CORPORATION, PIXIUM VISION, Second Sight Medical Products, Inc., BIOTRONIK SE & Co. KG, MED-EL, SetPoint Medical, and Stimwave LLC, among others.

Table of Contents

Executive Summary

1. Product Definition

2. Scope of Work

  • 2.1. Overview: Report Scope
  • 2.2. Segmentation of the Global Bioelectric Medicine Market
  • 2.3. Assumptions and Limitations
  • 2.4. Key Questions Answered in the Report:
  • 2.5. Base Year and Forecast Period

3. Research Methodology

  • 3.1. Overview: Research Methodology

4. Industry Analysis

  • 4.1. Regulatory Scenario
    • 4.1.1. Legal Requirements and Regulations
    • 4.1.1.1. Regulations in the U.S.
    • 4.1.1.2. Regulations in Europe
    • 4.1.1.3. Regulations in Other Countries
  • 4.2. Patent Analysis
  • 4.3. Product Pipeline

5. Competitive Landscape

  • 5.1. Overview
  • 5.2. Key Strategies and Development (2016-2019)
    • 5.2.1. Product Launches, Approvals, and Clearances
    • 5.2.2. Joint Venture, Agreement, Collaborations, and Partnerships
    • 5.2.3. Mergers and Acquisitions
    • 5.2.4. Business Expansion
  • 5.3. Market Share Analysis of Spinal Cord Stimulation Devices in the Global Bioelectric Medicine Market
  • 5.4. Market Share Analysis of Cochlear Implant in the Global Bioelectric Medicine Market
  • 5.5. Market Share Analysis of Pacemaker and ICD in the Global Bioelectric Medicine Market
  • 5.6. Growth Share Analysis

6. Evolution of Bioelectric Medicine

  • 6.1. Evolution of the Pacemaker
  • 6.2. Enabling Technologies Evolving Pacemaker and ICD
  • 6.3. Evolution of the Neurostimulation Therapy
  • 6.4. Enabling Technologies Evolving Neurostimulation Therapies

7. Global Bioelectric Medicine Market, 2018-2025

  • 7.1. Assumptions and Limitations
  • 7.2. Global Market Scenario
  • 7.3. Market Dynamics
    • 7.3.1. Overview
    • 7.3.2. Impact Analysis
    • 7.3.3. Market Drivers
      • 7.3.3.1. Growing Geriatric Population Leads to Surge in Exigency of Bioelectric Medicine
      • 7.3.3.2. Increasing Burden of Disease Inciting the Use of Bioelectric Medicine
        • 7.3.3.2.1. Increasing Prevalence of Neurological Disorders
        • 7.3.3.2.2. Increasing Prevalence of Hearing Loss
        • 7.3.3.2.3. Increasing Prevalence of Cardiovascular Disorders
        • 7.3.3.2.4. Increasing Burden of Blindness
      • 7.3.3.3. Growing Investments and Funds for the Development of Novel Therapies and Electroceuticals
      • 7.3.3.4. Limited Success Rate of Drugs Targeting Specific Disease
      • 7.3.3.5. Increasing Amount of Adverse Drug Reaction
      • 7.3.3.6. Upsurge in Awareness Level
    • 7.3.4. Market Restraints
      • 7.3.4.1. Product Recall
      • 7.3.4.2. Exorbitant Cost of Electroceuticals
      • 7.3.4.3. Increased Regulatory Scrutiny
      • 7.3.4.4. Complications and Side-Effects Associated with the Bioelectric Medicine Devices
    • 7.3.5. Market Opportunities
      • 7.3.5.1. Growth in Emerging Countries
      • 7.3.5.2. Technological Advancement in Bioelectric Medicine
        • 7.3.5.2.1. Development of Closed Loop Neuromodulation
        • 7.3.5.2.2. Evolution of Biomarker-Based Therapeutics Enabling Early Diagnostics of Neurological Disorders
        • 7.3.5.2.3. Technological Advancement in Pacemakers
        • 7.3.5.2.4. Technological Advancement in ICDs

8. Global Bioelectric Medicine Market by Product Type, 2018-2025

  • 8.1. Overview
  • 8.2. Competitive Benchmarking
  • 8.3. Implantable Bioelectric Medicine
    • 8.3.1. Cardiac Pacemaker
    • 8.3.2. Implantable Cardioverter Defibrillators (ICD)
    • 8.3.3. Spinal Cord Stimulation Device
    • 8.3.4. Cochlear Implants
    • 8.3.5. Deep Brain Stimulation Device
    • 8.3.6. Vagus Nerve Stimulation Device
    • 8.3.7. Others
    • 8.4. Non-Implantable Bioelectric Medicine

9. Global Bioelectric Medicine Market (by Region)

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. North America: Bioelectric Medicine Market by Product
      • 9.2.1.1. North America: Implantable Bioelectric Medicine Market by Product
    • 9.2.2. North America: Bioelectric Medicine Market by Country
      • 9.2.2.1. U.S.
        • 9.2.2.1.1. U.S.: Bioelectric Medicine Market by Product
          • 9.2.2.1.1.1. U.S.: Implantable Bioelectric Medicine Market by Product
      • 9.2.2.2. Canada
        • 9.2.2.2.1. Canada: Bioelectric Medicine Market by Product
          • 9.2.2.2.1.1. Canada: Implantable Bioelectric Medicine Market by Product
  • 9.3. Europe
    • 9.3.1. Europe: Bioelectric Medicine Market by Product
      • 9.3.1.1. Europe: Implantable Bioelectric Medicine Market by Product
    • 9.3.2. Europe: Bioelectric Medicine Market by Country
      • 9.3.2.1. Germany
        • 9.3.2.1.1. Germany: Bioelectric Medicine Market by Product Type
          • 9.3.2.1.1.1. Germany: Implantable Bioelectric Medicine Market by Product
      • 9.3.2.2. U.K.
        • 9.3.2.2.1. U.K.: Bioelectric Medicine Market by Product
          • 9.3.2.2.1.1. U.K.: Implantable Bioelectric Medicine Market by Product
      • 9.3.2.3. France
        • 9.3.2.3.1. France: Bioelectric Medicine Market by Product
          • 9.3.2.3.1.1. France: Implantable Bioelectric Medicine Market by Product
      • 9.3.2.4. Italy
        • 9.3.2.4.1. Italy: Bioelectric Medicine Market by Product
          • 9.3.2.4.1.1. Italy: Implantable Bioelectric Medicine Market by Product
      • 9.3.2.5. Spain
        • 9.3.2.5.1. Spain: Bioelectric Medicine Market by Product
          • 9.3.2.5.1.1. Spain: Implantable Bioelectric Medicine Market by Product
      • 9.3.2.6. Rest-of-Europe
        • 9.3.2.6.1. Rest-of-Europe: Bioelectric Medicine Market by Product
          • 9.3.2.6.1.1. Rest-of-Europe: Implantable Bioelectric Medicine Market by Product
  • 9.4. Asia-Pacific
    • 9.4.1. Asia-Pacific: Bioelectric Medicine Market by Product
      • 9.4.1.1. Asia-Pacific: Implantable Bioelectric Medicine Market by Product
    • 9.4.2. Asia-Pacific: Bioelectric Medicine Market by Country
      • 9.4.2.1. Japan
        • 9.4.2.1.1. Japan: Bioelectric Medicine Market by Product
          • 9.4.2.1.1.1. Japan: Implantable Bioelectric Medicine Market by Product
      • 9.4.2.2. China
        • 9.4.2.2.1. China: Bioelectric Medicine Market by Product
          • 9.4.2.2.1.1 China: Implantable Bioelectric Medicine Market by Product
      • 9.4.2.3. India
        • 9.4.2.3.1. India: Bioelectric Medicine Market by Product
          • 9.4.2.3.1.1. India: Implantable Bioelectric Medicine Market by Product
      • 9.4.2.4. South Korea
        • 9.4.2.4.1. South Korea: Bioelectric Medicine Market by Product
          • 9.4.2.4.1.1. South Korea: Implantable Bioelectric Medicine Market by Product
      • 9.4.2.5. Rest-of-Asia-Pacific
        • 9.4.2.5.1. Rest-of-Asia-Pacific: Bioelectric Medicine Market by Product
          • 9.4.2.5.1.1. Rest-of-Asia-Pacific: Implantable Bioelectric Medicine Market by Product
  • 9.5. Latin America
    • 9.5.1. Latin America: Bioelectric Medicine Market by Product
      • 9.5.1.1. Latin America: Implantable Bioelectric Medicine Market by Product
    • 9.5.2. Latin America: Bioelectric Medicine Market by Country
      • 9.5.2.1. Brazil
        • 9.5.2.1.1. Brazil: Bioelectric Medicine Market by Product
          • 9.5.2.1.1.1. Brazil: Implantable Bioelectric Medicine Market by Product
      • 9.5.2.2. Mexico
        • 9.5.2.2.1. Mexico: Bioelectric Medicine Market by Product
          • 9.5.2.2.1.1. Mexico: Implantable Bioelectric Medicine Market by Product
      • 9.5.2.3. Rest-of-Latin America
        • 9.5.2.3.1. Rest-of-Latin America: Bioelectric Medicine Market by Product
          • 9.5.2.3.1.1. Rest-of-Latin America: Implantable Bioelectric Medicine Market by Product
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa: Bioelectric Medicine Market by Product
      • 9.6.1.1. Middle East and Africa: Implantable Bioelectric Medicine Market by Product

10. Company Profile

  • 10.1. Overview
  • 10.2. Abbott Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financials
    • 10.2.3. Role of Abbott Laboratories in the Bioelectric Medicines Market
    • 10.2.4. SWOT Analysis
  • 10.3. Boston Scientific Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Role of Boston Scientific Corporation in the Bioelectric Medicines Market
    • 10.3.4. SWOT Analysis
  • 10.4. BIOTRONIK SE & Co. KG
    • 10.4.1. Company Overview
    • 10.4.2. Role of BIOTRONIK SE & Co. KG in the Bioelectric Medicines Market
    • 10.4.3. SWOT Analysis
  • 10.5. Cochlear Limited
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Role of Cochlear Limited in the Bioelectric Medicines Market
    • 10.5.4. SWOT Analysis
  • 10.6. electroCore, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Role of electroCore, Inc. in the Bioelectric Medicines Market
    • 10.6.4. SWOT Analysis
  • 10.7. Inspire Medical Systems, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Role of Inspire Medical Systems, Inc. in the Bioelectric Medicines Market
    • 10.7.4. SWOT Analysis
  • 10.8. LivaNova Plc
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Role of LivaNova, Plc in the Bioelectric Medicines Market
    • 10.8.4. SWOT Analysis
  • 10.9. Medtronic Plc
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Role of Medtronic Plc in the Bioelectric Medicine Market
    • 10.9.4. SWOT Analysis
  • 10.10 MED-EL
    • 10.10.1. Company Overview
    • 10.10.2. Role of MED-EL in the Bioelectric Medicines Market
    • 10.10.3. SWOT Analysis
  • 10.11 Nevro Corp.
    • 10.11.1. Company Overview
    • 10.11.2. Financials
    • 10.11.3. Role of Nevro Corp. in the Bioelectric Medicines Market
    • 10.11.4. SWOT Analysis
  • 10.12 Nuvectra Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financials
    • 10.12.3. Role of Nuvectra Corporation in the Bioelectric Medicines Market
    • 10.12.4. SWOT Analysis
  • 10.13 NeuroMetrix, Inc
    • 10.13.1. Company Overview
    • 10.13.2. Financials
    • 10.13.3. Role of NeuroMetrix, Inc. in the Bioelectric Medicines Market
    • 10.13.4. SWOT Analysis
  • 10.14 OMRON CORPORATION
    • 10.14.1. Company Overview
    • 10.14.2. Financials
    • 10.14.3. Role of Omron Corporation in the Global Bioelectric Medicine Market
    • 10.14.4. SWOT Analysis
  • 10.15 PIXIUM VISION
    • 10.15.1. Company Overview
    • 10.15.2. Role of PIXIUM VISION in the Bioelectric Medicines Market
    • 10.15.3. SWOT Analysis
  • 10.16 Second Sight Medical Products, Inc.
    • 10.16.1. Company Overview
    • 10.16.2. Financials
    • 10.16.3. Role of Second Sight Medical Products, Inc. in the Bioelectric Medicines Market
    • 10.16.4. SWOT Analysis
  • 10.17 SetPoint Medical
    • 10.17.1. Company Overview
    • 10.17.2. Role of SetPoint Medical in the Bioelectric Medicines Market
    • 10.17.3. SWOT Analysis
  • 10.18 Stimwave LLC
    • 10.18.1. Company Overview
    • 10.18.2. Role of Stimwave LLC in the Bioelectric Medicines Market
    • 10.18.3. SWOT Analysis

List of Tables

  • Table 4.1: Regulatory Authorities/ Associations/ Consortium of the Global Bioelectric Medicine Market
  • Table 4.2: Some of the Product Pipeline for Bioelectric Medicine Market
  • Table 7.1: Leading Cause of Disability in 1990 and 2017
  • Table 7.2: Global Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 7.3: Projected Hearing Loss Population Across the Globe
  • Table 7.4: Prevalence of Hearing Loss Across the World
  • Table 7.5: Bioelectric Medicine Growing Investment
  • Table 7.6: Some of the Funding in Bioelectric Medicine
  • Table 7.7: Some of the Product Recall of the Bioelectric Medicine
  • Table 8.1: Competitive Benchmarking by Product
  • Table 8.2: Some of the Clinical Studies Undergoing for Cardiac Pacemaker
  • Table 8.3: Pacemaker in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
  • Table 8.4: Some of the Clinical Studies Undergoing for ICD
  • Table 8.5: ICD in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
  • Table 8.6: Some of the Clinical Studies Undergoing for Spinal Cord Stimulation Device
  • Table 8.7: Specification of Different Spinal Cord Stimulation Device Offered by Different Companies
  • Table 8.8: Spinal Cord Stimulation Device in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
  • Table 8.9: Some of the Clinical Studies Undergoing for Cochlear Implant
  • Table 8.10: Cochlear Implant in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
  • Table 8.11: Some of the Clinical Studies Undergoing for Deep Brain Stimulation
  • Table 8.12: Deep Brain Stimulation in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
  • Table 8.13: Some of the Clinical Studies Undergoing for Vagus Nerve Stimulation
  • Table 8.14: Vagus Nerve Stimulation in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
  • Table 8.15: Others in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
  • Table 8.16: Non-Implantable in the Global Bioelectric Medicine Market (by Region) 2018-2025, $Million
  • Table 9.1: North America Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.2: Cardiac Procedure Volume in the U.S., 2014
  • Table 9.3: U.S. Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.4: Canada Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.5: Implantation of Pacemaker and ICDs
  • Table 9.6: Europe Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.7: Germany Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.8: U.K. Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.9: France Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.10: Italy Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.11: Spain Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.12: Asia Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.13: Units of Pacemaker and ICDs in Asia-Pacific Region
  • Table 9.14: Japan Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.15: China Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.16: India Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.17: South Korea Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.18: Latin America and Caribbean Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.19: Brazil Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.20: Mexico Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.21: Argentina Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.22: North Africa and Middle East Prevalence of Diseases Treated by Bioelectric Medicine, 2014-2017
  • Table 9.23: Pacemaker Implantation Rate Per Million Population in Africa from 2011-2016

List of Figures

  • Figure 1: Global Bioelectric Medicine Market Snapshot
  • Figure 2: Market Drivers and Market Restraints
  • Figure 3: Competitive Scenario of Spinal Cord Stimulation Device in the Global Bioelectric Medicine Market
  • Figure 4: Global Bioelectric Medicine Market, 2018-2025
  • Figure 5: Growth Share Matrix of Products, 2018
  • Figure 1.1: Examples of Diseases that are Potential Target for Bioelectric Medicine
  • Figure 2.1: Global Bioelectric Medicine: Market Segmentation
  • Figure 3.1: Bioelectric Medicine Market Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Data Triangulation
  • Figure 3.5: Top-Down Approach (Segment-Wise Analysis)
  • Figure 3.6: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.7: Assumptions and Limitations
  • Figure 3.8: Considered Factors for Data Prediction and Modeling
  • Figure 4.1: Share of Patent by Ownership, January 2016- July 2019
  • Figure 5.1: Competitive Landscape
  • Figure 5.2: Share of Key Developments and Strategies- January 2016- July 2019
  • Figure 5.3: Product Launches, Approvals, and Clearances (by Company), January 2016 -July 2019
  • Figure 5.4: Agreements, Collaborations, Joint Ventures, and Partnership (by Company). January 2016-July 2019
  • Figure 5.5: Mergers and Acquisitions (by Company), January 2016-July 2019
  • Figure 5.6: Business Expansion (by Company), January 2016- July 2019
  • Figure 5.7: Market Share Analysis (by Company), for Spinal Cord Stimulation Devices in the Bioelectric Medicine Market, 2018
  • Figure 5.8: Market Share Analysis (by Company), for Cochlear Implant in the Global Bioelectric Medicine Market, 2018
  • Figure 5.9: Market Share Analysis (by Company), for Pacemaker and ICD in the Global Bioelectric Medicine Market, 2018
  • Figure 5.10: Growth Share Matrix for Global Implantable Bioelectric Medicine Market, by Products, 2018
  • Figure 6.1: Evolution of Pacemaker and ICD
  • Figure 6.2: FDA Approval Indications by Various Vendor Products
  • Figure 7.1: Segmentation of Bioelectric Medicine Market
  • Figure 7.2: Global Bioelectric Medicine Market, 2018-2025
  • Figure 7.3: Drivers, Restraints, and Opportunities of the Global Bioelectric Medicine Market
  • Figure 7.4: Impact Analysis
  • Figure 7.5: Geriatric Population (60 years and above) Worldwide in Different Regions, 2000, 2015, 2030, 2050
  • Figure 7.6: U.S. Annual Alzheimer's Death Rate (per 100,000 People) by Year
  • Figure 8.1: Segmentation of Bioelectric Medicine Market, by Product Type
  • Figure 8.2: Global Bioelectric Medicine Market, by Product Type, Market Share 2018
  • Figure 8.3: Implantable Bioelectric Medicine in the Global Bioelectric Medicine Market, 2018 and 2025
  • Figure 8.4: Mechanism of Action Pacemaker
  • Figure 8.5: Pacemaker in the Global Bioelectric Medicine Market, 2018-2025
  • Figure 8.6: Mechanism Action of ICD
  • Figure 8.7: ICD in the Global Bioelectric Medicine Market, 2018-2025
  • Figure 8.8: Mechanism Action of Spinal Cord Stimulation Device
  • Figure 8.9: Spinal Cord Stimulation Device in the Global Bioelectric Medicine Market, 2018-2025
  • Figure 8.10: Mechanism of Action of Cochlear Implants
  • Figure 8.11: Cochlear Implant in the Global Bioelectric Medicine Market, 2018-2025
  • Figure 8.12: Deep Brain Stimulation Device in the Global Bioelectric Medicine Market. 2018-2025
  • Figure 8.13: Vagus Nerve Stimulation Device in the Global Bioelectric Medicine Market. 2018-2025
  • Figure 8.14: Others in the Global Bioelectric Medicine Market. 2018-2025
  • Figure 8.15: Non-Implantable in the Global Bioelectric Medicine Market. 2018-2025
  • Figure 9.1: Global Bioelectric Medicine Market Scenario, 2018
  • Figure 9.2: North America: Bioelectric Medicine Market, 2018-2025
  • Figure 9.3: North America: Market Dynamics
  • Figure 9.4: North America: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.5: North America: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.6: North America: Bioelectric Medicine Market (by Country), 2018 and 2025
  • Figure 9.7: Alzheimer's Dementia in Different Age Groups in the U.S., 2018
  • Figure 9.8: U.S.: Bioelectric Medicine Market, 2018-2025
  • Figure 9.9: U.S.: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.10: U.S.: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.11: Canada: Bioelectric Medicine Market, 2018-2025
  • Figure 9.12: Canada: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.13: Canada: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.14: Number of People with Parkinson's Disease in Different European Countries
  • Figure 9.15: Europe: Bioelectric Medicine Market, 2018-2025
  • Figure 9.16: Europe: Market Dynamics
  • Figure 9.17: Europe: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.18: Europe: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.19: Europe: Bioelectric Medicine Market (by Country), 2018 and 2025
  • Figure 9.20: Germany: Bioelectric Medicine Market, 2018-2025
  • Figure 9.21: Germany: Bioelectric Medicine Market (by Product Type), 2018-2025
  • Figure 9.22: Germany: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.23: U.K.: Bioelectric Medicine Market, 2018-2025
  • Figure 9.24: U.K.: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.25: U.K.: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.26: France: Bioelectric Medicine Market, 2018-2025
  • Figure 9.27: France: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.28: France: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.29: Italy: Bioelectric Medicine Market, 2018-2025
  • Figure 9.30: Italy: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.31: Italy: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.32: Spain: Bioelectric Medicine Market, 2018-2025
  • Figure 9.33: Spain: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.34: Spain: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.35: Rest-of-Europe: Bioelectric Medicine Market, 2018-2025
  • Figure 9.36: Rest-of-Europe: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.37: Rest-of-Europe: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.38: Asia-Pacific: Bioelectric Medicine Market, 2018-2025
  • Figure 9.39: Asia-Pacific: Market Dynamics
  • Figure 9.40: Asia-Pacific: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.41: Asia-Pacific: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.42: Asia-Pacific: Bioelectric Medicine Market (by Country), 2018 and 2025
  • Figure 9.43: Japan: Bioelectric Medicine Market, 2018-2025
  • Figure 9.44: Japan: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.45: Japan: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.46: China: Bioelectric Medicine Market, 2018-2025
  • Figure 9.47: China: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.48: China: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.49: India: Bioelectric Medicine Market, 2018-2025
  • Figure 9.50: India: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.51: India: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.52: South Korea: Bioelectric Medicine Market, 2018-2025
  • Figure 9.53: South Korea: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.54: South Korea: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.55: Rest-of-Asia-Pacific: Bioelectric Medicine Market, 2018-2025
  • Figure 9.56: Rest-of-Asia-Pacific: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.57: Rest-of-Asia-Pacific: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.58: Latin America: Bioelectric Medicine Market, 2018-2025
  • Figure 9.59: Latin America: Market Dynamics
  • Figure 9.60: Latin America: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.61: Latin America: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.62: Latin America: Bioelectric Medicine Market (by Country), 2018 and 2025
  • Figure 9.63: Brazil: Bioelectric Medicine Market, 2018-2025
  • Figure 9.64: Brazil: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.65: Brazil: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.66: Mexico: Bioelectric Medicine Market, 20182025
  • Figure 9.67: Mexico: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.68: Mexico: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.69: Rest-of-Latin America: Bioelectric Medicine Market, 2018-2025
  • Figure 9.70: Rest-of-Latin America: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.71: Rest-of-Latin America: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.72: Middle East and Africa: Bioelectric Medicine Market, 2018-2025
  • Figure 9.73: Middle East and Africa: Market Dynamics
  • Figure 9.74: Middle East and Africa: Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 9.75: Middle East and Africa: Implantable Bioelectric Medicine Market (by Product), 2018-2025
  • Figure 10.1: Total Number of Companies Profiles
  • Figure 10.2: Abbott Laboratories: Overall Financials, 2016-2018
  • Figure 10.3: Abbott Laboratories - Revenue (by Segment), 2016-2018
  • Figure 10.4: Abbott Laboratories - Revenue (by Region), 2016-2018
  • Figure 10.5: Abbott Laboratories - Research and Development Expense, 2016-2018
  • Figure 10.6: Abbott Laboratories: Overall Product Portfolio
  • Figure 10.7: SWOT Analysis - Abbott Laboratories
  • Figure 10.8: Boston Scientific Corporation: Overall Financials, 2016-2018
  • Figure 10.9: Boston Scientific Corporation - Revenue (by Segment), 2016-2018
  • Figure 10.10: Boston Scientific Corporation - Research and Development Expense, 2016-2018
  • Figure 10.11: Boston Scientific Corporation: Overall Product Portfolio
  • Figure 10.12: SWOT Analysis - Boston Scientific Corporation
  • Figure 10.13: BIOTRONIK SE & Co. KG: Overall Product Portfolio
  • Figure 10.14: SWOT Analysis - BIOTRONIK SE & Co. KG
  • Figure 10.15: Cochlear Limited: Overall Financials, 2016-2018
  • Figure 10.16: Cochlear Limited - Revenue (by Segment), 2016-2018
  • Figure 10.17: Cochlear Limited - Revenue (by Region), 2016-2018
  • Figure 10.18: Cochlear Limited - Research and Development Expense, 2016-2018
  • Figure 10.19: Cochlear Limited: Overall Product Portfolio
  • Figure 10.20: SWOT Analysis - Cochlear Limited
  • Figure 10.21: electroCore, Inc.: Overall Financials, 2016-2018
  • Figure 10.22: electroCore, Inc - Research and Development Expense, 2016-2018
  • Figure 10.23: electroCore, Inc.: Overall Product Portfolio
  • Figure 10.24: SWOT Analysis - electroCore, Inc.
  • Figure 10.25: Inspire Medical Systems, Inc.: Overall Financials, 2016-2018
  • Figure 10.26: Inspire Medical Systems, Inc. - Revenue (by Region), 2016-2018
  • Figure 10.27: Inspire Medical Systems, Inc - Research and Development Expense, 2016-2018
  • Figure 10.28: Inspire Medical Systems, Inc.: Overall Product Portfolio
  • Figure 10.29: SWOT Analysis - Inspire Medical Systems, Inc.
  • Figure 10.30: LivaNova Plc: Overall Financials, 2016-2018
  • Figure 10.31: LivaNova Plc - Revenue (by Segment), 2016-2018
  • Figure 10.32: LivaNova Plc - Revenue (by Region), 2016-2018
  • Figure 10.33: LivaNova, Plc - Research and Development Expense, 2016-2018
  • Figure 10.34: LivaNova, Plc.: Overall Product Portfolio
  • Figure 10.35: SWOT Analysis - LivaNova Plc
  • Figure 10.36: Medtronic Plc - Overall Financials, 2017-2019
  • Figure 10.37: Medtronic Plc - Revenue (by Segment), 2017-2019
  • Figure 10.38: Medtronic Plc - Revenue (by Region), 2017-2019
  • Figure 10.39: Medtronic Plc - Research and Development Expense, 2017-2019
  • Figure 10.40: Medtronic Plc - Product Portfolio for Bioelectric Medicine Market
  • Figure 10.41: SWOT Analysis - Medtronic Plc
  • Figure 10.42: MED-EL: Overall Product Portfolio
  • Figure 10.43: SWOT Analysis - MED-EL
  • Figure 10.44: Nevro Corp.: Overall Financials, 2016-2018
  • Figure 10.45: Nevro Corp. - Revenue (by Region), 2016-2018
  • Figure 10.46: Nevro Corp. - Research and Development Expense, 2016-2018
  • Figure 10.47: Nevro Corp.: Overall Product Portfolio
  • Figure 10.48: SWOT Analysis - Nevro Corp.
  • Figure 10.49: Nuvectra Corporation: Overall Financials, 2016-2018
  • Figure 9.50: Nuvectra Corporation: Revenue (by Region), 2016-2018
  • Figure 10.51: Nuvectra Corporation: R&D Expenditure, 2016-2018
  • Figure 10.52: Nuvectra Corporation: Overall Product Portfolio
  • Figure 10.53: SWOT Analysis -Nuvectra Corporation
  • Figure 10.54: NeuroMetrix, Inc.: Overall Financials, 2016-2018
  • Figure 10.55: NeuroMetrix, Inc.: Overall Product Portfolio
  • Figure 10.56: SWOT Analysis - NeuroMetrix, Inc.
  • Figure 10.57: Omron Corporation - Overall Financials, 2015-2017
  • Figure 10.58: Omron Corporation: Revenue by Segment, 2015-2017
  • Figure 10.59: Omron Corporation: Revenue by Region, 2015-2017
  • Figure 10.60: Omron Corporation: R&D Expenditure, 2015-2017
  • Figure 10.61: Omron Corporation - Product Portfolio for Global Bioelectric Medicine Market
  • Figure 10.62: SWOT Analysis - Omron Corporation
  • Figure 10.63: PIXIUM VISION: Overall Product Portfolio
  • Figure 10.64: SWOT Analysis - PIXIUM VISION
  • Figure 10.65: Second Sight Medical Products, Inc.: Overall Financials, 2016-2018
  • Figure 10.66: Second Sight Medical Products, Inc. - Research and Development Expense, 2016-2018
  • Figure 10.67: Second Sight Medical Products, Inc.: Overall Product Portfolio
  • Figure 10.68: SWOT Analysis - Second Sight Medical Products, Inc.
  • Figure 10.69: SetPoint Medical: Overall Product Portfolio
  • Figure 10.70: SWOT Analysis - SetPoint Medical
  • Figure 10.71: Stimwave LLC: Overall Product Portfolio
  • Figure 10.72: SWOT Analysis - Stimwave LLC